NCT02762097

Brief Summary

Polyps are fleshy outgrowths of the inner lining of the womb which may hinder implantation of embryo and lead to subfertility.This study evaluates whether removal of endometrial polyps in womb affects chances of pregnancy in women in whom no other causes of subfertility can be found. Half of the women would have these polyps removed after their consent and the other half who would not consent would not undergo any such intervention

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2017

Typical duration for phase_3

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 4, 2016

Completed
9 months until next milestone

Study Start

First participant enrolled

January 30, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2020

Completed
Last Updated

November 6, 2018

Status Verified

November 1, 2018

Enrollment Period

3 years

First QC Date

April 30, 2016

Last Update Submit

November 3, 2018

Conditions

Keywords

polypssaline sonographyinfertility

Outcome Measures

Primary Outcomes (1)

  • Clinical pregnancy rate:

    number of women who get pregnancy test positive within 12 months of intervention

    12 months

Study Arms (2)

intervention

EXPERIMENTAL

All women would undergo saline sonography with normal saline. Women with endometrial polyps who consent to the removal of polyps will be offered polypectomy

Procedure: polypectomyProcedure: saline sonographyDrug: normal saline

control

PLACEBO COMPARATOR

All women would undergo saline sonography with normal saline. Women with endometrial polyps who do not consent to the removal would serve as controls

Procedure: saline sonographyDrug: normal saline

Interventions

polypectomyPROCEDURE

. During the second visit after she consents to removal of polyp revealed on prior saline sonography, a dilatation and curettage would be performed under ultrasound guidance and after successful removal of polyp (polypectomy) saline sonography would be repeated to ensure completeness of removal.

intervention

saline infusion sonography (SIS) on 8th to 11th day of menstrual cycle. On the day of admission SIS will be performed in an outpatient setting .Taking all aseptic measures a speculum will be inserted vaginally and up to 20 ml of sterile saline solution will be infused into the uterine cavity through a cervical foley's catheter of 5 french to distend the endometrial cavity. A transvaginal transducer will be used to scan the uterine cavity. In case the patient has polyps she would be offered removal under general anaesthesia on a subsequent visit as a day case procedure.

controlintervention

Normal saline would be injected into uterine cavity to delineate defects

controlintervention

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Normal semen analysis
  • months of unprotected sexual intercourse
  • NORMAL TVS
  • Normal hysterosalpingogram
  • Evidence of spontaneous ovulation
  • No history of Pelvic inflammatory disease
  • Polyps on saline sonography

You may not qualify if:

  • History of taking hormones
  • Thyroid disorder
  • prior hysteroscopy treatment
  • intermenstrual blood loss.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

InfertilityPolyps

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations
0

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
research assistant

Study Record Dates

First Submitted

April 30, 2016

First Posted

May 4, 2016

Study Start

January 30, 2017

Primary Completion

January 30, 2020

Study Completion

January 30, 2020

Last Updated

November 6, 2018

Record last verified: 2018-11